Image Quality Assurance in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Network of the National Lung Screening Trial

被引:0
|
作者
Stephen M. Moore
David S. Gierada
Kenneth W. Clark
G. James Blaine
机构
[1] Washington University,Mallinckrodt Institute of Radiology
来源
Journal of Digital Imaging | 2005年 / 18卷
关键词
Clinical trial; quality assurance; VPN; NLST;
D O I
暂无
中图分类号
学科分类号
摘要
The National Lung Screening Trial is evaluating the effectiveness of low-dose spiral CT and conventional chest X-ray as screening tests for persons who are at high risk for developing lung cancer. This multicenter trial requires quality assurance (QA) for the image quality and technical parameters of the scans. The electronic system described here helps manage the QA process. The system includes a workstation at each screening center that de-identifies the data, a DICOM storage service at the QA Coordinating Center, and Web-based systems for presenting images and QA evaluation forms to the QA radiologists. Quality assurance data are collated and analyzed by an independent statistical organization. We describe the design and implementation of this electronic QA system, emphasizing issues relating to data security and privacy, the various obstacles encountered in the installation of a common system at different participating screening centers, and the functional success of the system deployed.
引用
收藏
页码:242 / 250
页数:8
相关论文
共 50 条
  • [21] Coordination and management of a large multicenter screening trial: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    O'Brien, B
    Nichaman, L
    Browne, JEH
    Levin, DL
    Prorok, PC
    Gohagan, JK
    Sullivan, D
    CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 310S - 328S
  • [22] Recruitment methods employed in the prostate, lung, colorectal, and ovarian cancer screening trial
    Gren, Lisa
    Broski, Karen
    Childs, Jeffery
    Cordes, Jill
    Engelhard, Deborah
    Gahagan, Betsy
    Gamito, Eduard
    Gardner, Vivien
    Geisser, Mindy
    Higgins, Darlene
    Jenkins, Victoria
    Lamerato, Lois
    Lappe, Karen
    Lowery, Heidi
    McGuire, Colleen
    Miedzinski, Mollie
    Ogden, Sheryl
    Tenorio, Sally
    Watt, Gavin
    Wohlers, Bonita
    Marcus, Pamela
    CLINICAL TRIALS, 2009, 6 (01) : 52 - 59
  • [23] Black participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    Stallings, FL
    Ford, ME
    Simpson, NK
    Fouad, M
    Jernigan, JC
    Trauth, JM
    Miller, DS
    CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 379S - 389S
  • [24] Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: Findings from the initial screen of a randomized trial
    Buys, SS
    Partridge, E
    Greene, MH
    Prorok, PC
    Reding, D
    Riley, TL
    Hartge, P
    Fagerstrom, RM
    Chia, D
    Izmirlian, G
    Fouad, M
    Ragard, LR
    Johnson, CC
    Gohagan, JK
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 193 (05) : 1630 - 1639
  • [25] Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens
    Cramer, Daniel W.
    Bast, Robert C., Jr.
    Berg, Christine D.
    Diamandis, Eleftherios P.
    Godwin, Andrew K.
    Hartge, Patricia
    Lokshin, Anna E.
    Lu, Karen H.
    McIntosh, Martin W.
    Mor, Gil
    Patriotis, Christos
    Pinsky, Paul F.
    Thornquist, Mark D.
    Scholler, Nathalie
    Skates, Steven J.
    Sluss, Patrick M.
    Srivastava, Sudhir
    Ward, David C.
    Zhang, Zhen
    Zhu, Claire S.
    Urban, Nicole
    CANCER PREVENTION RESEARCH, 2011, 4 (03) : 365 - 374
  • [26] Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
    Michael F. Leitzmann
    Jiyoung Ahn
    Demetrius Albanes
    Ann W. Hsing
    Arthur Schatzkin
    Shih-Chen Chang
    Wen-Yi Huang
    Jocelyn M. Weiss
    Kim N. Danforth
    Robert L. Grubb
    Gerald L. Andriole
    Cancer Causes & Control, 2008, 19 : 1267 - 1276
  • [27] Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
    Leitzmann, Michael F.
    Ahn, Jiyoung
    Albanes, Demetrius
    Hsing, Ann W.
    Schatzkin, Arthur
    Chang, Shih-Chen
    Huang, Wen-Yi
    Weiss, Jocelyn M.
    Danforth, Kim N.
    Grubb, Robert L., III
    Andriole, Gerald L.
    CANCER CAUSES & CONTROL, 2008, 19 (10) : 1267 - 1276
  • [28] Prostate cancer specific survival in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
    Pinsky, Paul F.
    Black, Amanda
    Parnes, Howard L.
    Grubb, Robert
    Crawford, E. David
    Miller, Anthony
    Reding, Douglas
    Andriole, Gerald
    CANCER EPIDEMIOLOGY, 2012, 36 (06) : E401 - E406
  • [29] Lung Cancer Risk Prediction: Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Models and Validation
    Tammemagi, C. Martin
    Pinsky, Paul F.
    Caporaso, Neil E.
    Kvale, Paul A.
    Hocking, William G.
    Church, Timothy R.
    Riley, Thomas L.
    Commins, John
    Oken, Martin M.
    Berg, Christine D.
    Prorok, Philip C.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (13): : 1058 - 1068
  • [30] Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial
    Grubb, Robert L., III
    Pinsky, Paul F.
    Greenlee, Robert T.
    Izmirlian, Grant
    Miller, Anthony B.
    Hickey, Thomas P.
    Riley, Thomas L.
    Mabie, Jerome E.
    Levin, David L.
    Chia, David
    Kramer, Barnett S.
    Reding, Douglas J.
    Church, Timothy R.
    Yokochi, Lance A.
    Kvale, Paul A.
    Weissfeld, Joel L.
    Urban, Donald A.
    Buys, Saundra S.
    Gelmann, Edward P.
    Ragard, Lawrence R.
    Crawford, E. David
    Prorok, Philip C.
    Gohagan, John K.
    Berg, Christine D.
    Andriole, Gerald L.
    BJU INTERNATIONAL, 2008, 102 (11) : 1524 - 1530